Literature DB >> 12417351

Neuropsychological differentiation of small vessel disease, Alzheimer's disease and mixed dementia.

Klaus Schmidtke1, Michael Hüll.   

Abstract

This study examined the neuropsychological profile of probable Alzheimer's disease (AD, n=72), vascular dementia due to diffuse subcortical small vessel disease (SVD, n=18) and mixed dementia (AD+SVD, n=18). Five simple tests were analysed, i.e. verbal recall and recognition memory, object naming, word fluency and clock reading. Pairwise discriminant analyses classified 79-83% of the cases correctly. Mixed dementia (MD) patients showed lower word fluency; otherwise, their profile was indistinguishable from AD. Recognition memory and clock reading were identified as predictors of SVD vs. AD diagnosis. The potential of single variables to distinguish the groups was tested by receiver operator characteristic curve analysis. A clock reading cut-off score close to maximum separated SVD from AD and MD. Recognition memory separated SVD from AD. These results show that neuropsychological tests can distinguish SVD and MD from AD with high sensitivity (88-94%). Due to the overlapping of scores and a higher prevalence of AD, specificity was moderate (65-76%) and positive predictive values were low, whereas sensitivity and negative predictive indices were high.

Entities:  

Mesh:

Year:  2002        PMID: 12417351     DOI: 10.1016/s0022-510x(02)00254-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Cognitive profile of subcortical ischaemic vascular disease.

Authors:  H Jokinen; H Kalska; R Mäntylä; T Pohjasvaara; R Ylikoski; M Hietanen; O Salonen; M Kaste; T Erkinjuntti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-01       Impact factor: 10.154

2.  Diagnostic Accuracy of Memory Measures in Alzheimer's Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  Gali H Weissberger; Jessica V Strong; Kayla B Stefanidis; Mathew J Summers; Mark W Bondi; Nikki H Stricker
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

3.  Posterior cortical atrophy: variant of Alzheimer's disease? A case series with PET findings.

Authors:  Klaus Schmidtke; Michael Hüll; Jochen Talazko
Journal:  J Neurol       Date:  2005-01       Impact factor: 4.849

Review 4.  [Differential diagnostics of dementia type diseases].

Authors:  W Reith; R Mühl-Benninghaus
Journal:  Radiologe       Date:  2015-05       Impact factor: 0.635

5.  The cognitive side of essential tremor: what are the therapeutic implications?

Authors:  Sarah C Janicki; Stephanie Cosentino; Elan D Louis
Journal:  Ther Adv Neurol Disord       Date:  2013-11       Impact factor: 6.570

6.  Importance of symptomatic cerebral infarcts on cognitive performance in patients with Alzheimer's disease.

Authors:  Soo-Jin Cho; Nikolaos Scarmeas; Tae-Won Jang; Karen Marder; Ming-Xin Tang; Lawrence S Honig
Journal:  J Korean Med Sci       Date:  2011-02-25       Impact factor: 2.153

7.  Investigating the association of ApoE genotypes with blood-brain barrier dysfunction measured by cerebrospinal fluid-serum albumin ratio in a cohort of patients with different types of dementia.

Authors:  André Karch; Henrike Manthey; Claudia Ponto; Peter Hermann; Uta Heinemann; Christian Schmidt; Inga Zerr
Journal:  PLoS One       Date:  2013-12-27       Impact factor: 3.240

8.  White matter hyperintensities and cognitive dysfunction in patients with infratentorial stroke.

Authors:  Tae Won Kim; Yun-Hee Kim; Kang Hee Kim; Won Hyuk Chang
Journal:  Ann Rehabil Med       Date:  2014-10-30

9.  CSF biomarkers and neuropsychological profiles in patients with cerebral small-vessel disease.

Authors:  Peter Hermann; Carlos Romero; Christian Schmidt; Clemens Reis; Inga Zerr
Journal:  PLoS One       Date:  2014-08-22       Impact factor: 3.240

10.  Mnemonic function in small vessel disease and associations with white matter tract microstructure.

Authors:  Athanasia Metoki; Rebecca L Brookes; Eva Zeestraten; Andrew J Lawrence; Robin G Morris; Thomas R Barrick; Hugh S Markus; Rebecca A Charlton
Journal:  Neuropsychologia       Date:  2017-07-24       Impact factor: 3.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.